Clinical Trials on Neoplasias primarias múltiples
Total 110395 results
-
Gangnam Severance HospitalCompletedInherited Retinal Dystrophy Primarily Involving Sensory Retina | Inherited Retinal Dystrophy Primarily Involving Retinal Pigment EpitheliumKorea, Republic of
-
Shahid Beheshti University of Medical SciencesUnknownInherited Retinal Dystrophy Primarily Involving Sensory Retina | Inherited Retinal Dystrophy Primarily Involving Retinal Pigment EpitheliumIran, Islamic Republic of
-
Ain Shams UniversityCompletedAdverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System
-
University of California, San FranciscoNational Cancer Institute (NCI); Food and Drug Administration (FDA)CompletedAdverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial EncounterUnited States
-
German Cancer Research CenterHeidelberg UniversityCompletedPrimarily Resectable Pancreatic CancerGermany
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
Towson UniversityDuke University; University of the Sciences in PhiladelphiaCompletedAnorexia Nervosa | Subthreshold Anorexia Nervosa | Eating Disorder Not Otherwise Specified, Primarily RestrictionUnited States
-
Retina Implant AGTerminatedRetinal Degeneration | Inherited Retinal Dystrophy Primarily Involving Sensory RetinaFrance
-
Centre Hospitalier Universitaire DijonUnknownType 1-Multiple Endocrine Neoplasia SyndromeFrance
-
Centre Hospitalier Universitaire DijonRecruitingMultiple Endocrine NeoplasiaFrance
-
Centre Hospitalier Universitaire DijonRecruiting
-
M.D. Anderson Cancer CenterActive, not recruitingMultiple Endocrine Neoplasia SyndromesUnited States
-
University of WashingtonRecruitingInherited Retinal Dystrophy Primarily Involving Sensory RetinaUnited States
-
National University Health System, SingaporeCompletedThymic Carcinoid | Multiple Endocrine Neoplasia Type 1 (MEN-1)Singapore
-
University Hospital, Basel, SwitzerlandRecruiting
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2 | Medullary Thyroid CarcinomaUnited States
-
RenJi HospitalUnknownMultiple Primary NeoplasmChina
-
National Taiwan University HospitalRecruiting
-
M.D. Anderson Cancer CenterCompletedMultiple Endocrine NeoplasiaUnited States
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Recurrent Thyroid Gland Medullary Carcinoma | Hereditary Thyroid Gland Medullary Carcinoma | Locally Advanced Thyroid Gland Medullary Carcinoma | Sporadic Thyroid Gland Medullary Carcinoma | Stage III Thyroid Gland Medullary... and other conditionsUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
National Institute of Diabetes and Digestive and...RecruitingPrimary Hyperparathyroidism | Pseudohypoparathyroidism | Parathyroid Cancer | Inheritable Bone Diseases | Multiple Endocrine Neoplasia, Type 1United States
-
J.M. de LaatRadboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsRecruitingPrecision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients (PRIME)Multiple Endocrine Neoplasia Type 1 | Neuroendocrine Tumor of PancreasNetherlands
-
Han weidongUnknownMalignancies MultipleChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNeuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Advanced Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Unresectable Carcinoid TumorUnited States
-
Guangxi Medical UniversityRecruitingPancreatic Neuroendocrine Tumor | Multiple Endocrine Neoplasia Type 1China
-
National Cancer Institute (NCI)CompletedPancreatic Neuroendocrine Carcinoma | Multiple Endocrine Neoplasia Type 1United States
-
Jersey Shore University Medical CenterRutgers University; Rutgers Cancer Institute of New JerseyCompletedPancreatic Cancer | Parathyroid Disease | Thymic Cancer | MEN1 SyndromeUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingGenetic Mutation | MEN1United States
-
Fudan UniversityNot yet recruiting
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
Children's Mercy Hospital Kansas CityKatherine Berry Richardson FoundationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMeningioma | Neuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Von Hippel-Lindau Syndrome | Metastatic Well Differentiated Neuroendocrine Neoplasm | Somatostatin Positive Neoplastic Cells PresentUnited States
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple Sites
-
National Institute of Diabetes and Digestive and...CompletedHyperparathyroidism | Multiple Endocrine Neoplasia | Hypercalcemia | MEN1 | Parathyroid NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign NeoplasmsUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
Sheba Medical CenterCompleted